Flegafortan, 0.8 mg/ml Flegafortan0,8mg/ml

Flegafortan, 0.8 mg/ml

Flegafortan syrup is indicated to treat chronic airway diseases with difficult expectoration (coughing up) of thick bronchial secretions (phlegm). Flegafortan contains an active ingredient which:

  • thins the mucus
  • clears bronchial passages
  • facilitates expectoration

Kategoria OTC

Additional information

Active substance

0.8 mg/mL bromohexine hydrochloride

Indications

Chronic and acute airway diseases with difficult expectoration (coughing up) of thick bronchial secretions (phlegm).

Contraindications

- Allergy to the active ingredient or any of the other components of the product.
- Flegafortan should not be used in children under 6 years of age.
- Do not use Flegafortan in patients with gastric and duodenal ulcers.

Marketing Authorisation Holder

Aflofarm Farmacja Polska Spółka z o.o.

Marketing Authorisation

24639

Information for the patient

Read the package leaflet for indications, contraindications, side effects, dosage as well as information on the use of this product, or consult your doctor or pharmacist before use. Misusing medicines may be dangerous to your life or health.

See how we care about quality

All our products are subject to strict safety requirements

We use rigorous quality control standards and procedures to ensure the highest level of safety for all our products.

See how we care about safety
This site uses cookies for services in accordance with the Privacy Policy